- Filed
- May 6, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · May 3, 2024 | 229.16M sh |
| Cash And Equivalents | Q2 2024 · Mar 31, 2024 | $673.59K |
| Cash And Equivalents | Q2 2024 · Sep 30, 2023 | $516.96K |
| Current Liabilities | Q2 2024 · Mar 31, 2024 | $1.58M |
| Current Liabilities | Q2 2024 · Sep 30, 2023 | $1.22M |
| Total Liabilities | Q2 2024 · Mar 31, 2024 | $1.63M |
| Total Liabilities | Q2 2024 · Sep 30, 2023 | $1.29M |
| Current Assets | Q2 2024 · Mar 31, 2024 | $1.42M |
| Current Assets | Q2 2024 · Sep 30, 2023 | $1.16M |
| Total Assets | Q2 2024 · Mar 31, 2024 | $1.68M |
| Total Assets | Q2 2024 · Sep 30, 2023 | $1.3M |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 599.48M sh |
| Shares Diluted | Q2 2024 · Mar 31, 2023 | 599.41M sh |
| Capex | Q2 2024 · Mar 31, 2023 | $4.32K |
| Operating Cash Flow | Q2 2024 · Mar 31, 2023 | −$78.1K |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $40.53K |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$34.3K |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | −$51.38K |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | $0.00 |
| Eps Diluted | Q2 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q2 2024 · Mar 31, 2023 | $0.00 |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $294.86K |
| Sga Expense | Q2 2024 · Mar 31, 2023 | $616.76K |
| Rd Expense | Q2 2024 · Mar 31, 2023 | $2K |
| Rd Expense | Q2 2024 · Mar 31, 2023 | $23.82K |
| Net Income | Q2 2024 · Mar 31, 2023 | $91.91K |
| Gross Profit | Q2 2024 · Mar 31, 2023 | $439.12K |
| Gross Profit | Q2 2024 · Mar 31, 2023 | $868.28K |
| Cost Of Revenue | Q2 2024 · Mar 31, 2023 | $71.55K |
| Cost Of Revenue | Q2 2024 · Mar 31, 2023 | $149.04K |
| Revenue | Q2 2024 · Mar 31, 2023 | $510.67K |
| Revenue | Q2 2024 · Mar 31, 2023 | $1.02M |